TENX
TENAX THERAPEUTICS INC
Latest close $13.47 as of Aug 5, 2026
Schedule 13G/13D reports beneficial ownership at an observation date. “Accumulation” or “reduction” is inferred
from changes in reported shares when available; it is not a list of individual trades or exact execution prices.
Form 13F rows are quarter-end holding context only and do not establish an exact entry date.
Free access includes current parsed ownership filings, reported share changes, and ownership-percentage changes.
Significance scoring, disclosure-speed analysis, confirmation/divergence signals, and signal alerts require Investor or Pro.
Compare plans.
Beneficial ownership filing history
Showing 3 of 6 parsed filing(s) · 3 older require more history access| Holder | Observed / filed | Reported change | Shares | Ownership | Observation | Filing | Latest |
|---|---|---|---|---|---|---|---|
| BlackRock CIK0002012383 | Jun 30, 2026 observed Jul 30, 2026 filed · 30d Initial Schedule 13G | Initial Schedule 13G | 1.7M | 12.00% | $14.55 | $15.10 | $13.47 |
| Fidelity / FMR CIK0000315066 | Jun 30, 2026 observed Jul 8, 2026 filed · 8d Initial Schedule 13G | Initial Schedule 13G | 3.9M | 14.90% | $14.55 | $17.73 | $13.47 |
| T. Rowe Price Associates CIK0000080255 | May 31, 2026 observed Jun 5, 2026 filed · 5d Schedule 13G amendment | Reported reduction | 587.0K -2.3M | 12.00% 0.00 pts | $11.87 | $10.73 | $13.47 |